Ambu has replaced its duodenoscopes the world over: "We have the product of choice"

Following a clinical study with 29 people, medtech company Ambu has already replaced its duodenoscopes on the global market. The company's CEO, Juan Jose Gonzalez, is sure the new version will beat competitors and become the preferred choice.

Juan Jose Gonzalez, CEO at Ambu, is very encouraged by the results of a study with the company's newest version of its duodenoscope. The products have thus already been replaced globally. | Photo: Ambu/PR

In connection with Ambu's newly released full-year financial report, the company has announced updating its duodenoscopes to a new version called Ascope Duodeno 1.5 for use in duodenoscopy procedures. Ambu CEO Juan Jose Gonazalez confirms to MedWatch that the product transition was initiated before the announcement.

"The replacement has been done already," the CEO says.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs